EDGAR Filing Documents for 0001193125-07-173877

Form 8-K - Current report:

SEC Accession No. 0001193125-07-173877

Filing Date

2007-08-07

Accepted

2007-08-07 17:13:02

Documents

Period of Report

2007-08-07

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	31805
2	EARNINGS PRESS RELEASE	dex991.htm	EX-99.1	75957
3	PRESS RELEASE	dex992.htm	EX-99.2	6221
4	PRESS RELEASE	dex993.htm	EX-99.3	5749
5	GRAPHIC	g70698img001.jpg	GRAPHIC	5672
	Complete submission text file	0001193125-07-173877.txt		129416

Mailing Address

Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939

NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)